//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
International research centre devoted to curing #cancer and other diseases linked to #aging. @cerca.cat center, member of @bist.eu. www.irbbarcelona.org
IRB Barcelona









Loading...
L'spin-off de l'#IRBBarcelona i @icreacommunity.bsky.social #OnaTherapeutics capta 74,2M€ per desenvolupar medicaments contra el càncer. 📰 @ara.cat  ✍️ Alberto Prieto #IRBInnovation #CancerResearch #Innovation
(2/3) Congratulations to Ines García, @crismayorruiz.bsky.social and all the contributors from the @irbbarcelona.org and from CIC Salamanca behind the recently published in the “Cancer Research” journal @aacrjournals.bsky.social: doi.org/10.1158/0008...
2d
5d
🧬 A highlight from the past couple of weeks: volunteering at the 2026 @irbbarcelona.org #OpenDay! We had the opportunity to engage with children, families, and visitors to showcase how #scientificresearch can make a real-world impact. 🌍
13h
The #SpinOff company #OnaTherapeutics raises $86.6M Series B funding to advance first-in-class ADCs into clinical development The global #biopharmaceutical company was launched in 2019 by the #BISTCommunity centre @irbbarcelona.org to address advanced #Cancer 👉 bist.eu/ona-therapeu...
10h
IRB Barcelona
📢 Join us for our Research Nodes #seminar this Wednesday, with Dr. Maria Rohm, from the Institute for Diabetes and Cancer at Helmholtz Munich. 🤝 Hosted by Metabolism in Physiology Interest Group (MIP) - #IRBBarcelona Register here ➡️ https://shorturl.at/5654O
🟠 #[email protected] spin-off #ONATherapeutics raises $86.6 M Series B to advance first-in-class ADCs into clinical development. ➡️ shorturl.at/dOwYZ #IRBInnovation #BreastCancer #ColonCancer #CancerResearch #Oncology @aznarbenitahlab.bsky.social @prat-aleix-md.bsky.social
A tumour-host feed-forward loop contributes to the growth of chromosomal instability-induced tumours. -> link.springer.com/article/10.1...
MS Proteomics
A new study led by @milanlab.bsky.social's team at  #IRBBarcelona shows that tumours with chromosomal instability can promote their own growth by damaging the surrounding healthy tissues. ➡️ https://shorturl.at/s4xr5 📌 @emboreports.org DOI: 10.1038/s44319-026-00811-7 #IRBScience #CancerResearch
We’re looking for outstanding undergraduate students to join us from September to July. Work with leading scientists from: ✔️ The mino Acid Transporters & Disease lab (Dr. Manuel Palacín) ✔️ The @mitotherapx-lab.bsky.social (@analechugavieco.bsky.social) 🗓️Apply by June 29 ➡️ https://shorturl.at/6lgfD
2d
6d
Structural Bioinformatics & Network Biology Lab
🦠 How did our cells originate? A study by #IRBBarcelona & @bsc-cns.bsky.social by @gabaldonlab.bsky.social, suggests cellular complexity arose through long-term microbial alliances rather than a single evolutionary event. @nature.com ➡️ https://shorturl.at/kCij7 📌 DOI: 10.1038/s41586-026-10639-9
5d
5d
1d
BIST-Barcelona Institute of Science and Technology
9h
IRB Barcelona
IRB Barcelona
IRB Barcelona
IRB Barcelona
EMBO Reports
IRB Barcelona
Abstract. Recent drug discovery breakthroughs led to the approval of KRASG12C inhibitors in lung adenocarcinoma (LUAD). Unfortunately, clinical responses are often hampered by the rapid resistance ons...
doi.org
Targeted KRASG12V Degradation in vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis
A new study led by @milanlab.bsky.social's team at  #IRBBarcelona shows that tumours with chromosomal instability can promote their own growth by damaging the surrounding healthy tissues. ➡️ https://shorturl.at/s4xr5 📌 @emboreports.org DOI: 10.1038/s44319-026-00811-7 #IRBScience #CancerResearch
5d
IRB Barcelona